Thursday, 12th September 10th Australian Peptide Conference 2013

Complimentary breakfast for those staying at the Golden Sands Resort and booked through ASN.

• Structure based design Hepatitis C Virus immunogens - Philip Dawson
• Extending chemical ligation - John Offer
• Different binding modes of antagonists and agonists at the relaxin-3 receptor RXFP3 - Johan Rosengren
• A strategy for stabilizing weak interactions of posttranslationally modified proteins - Christian F.W. Becker
• Bioorganic-inorganic materials and polymers from hybrid alkoxysilane-peptidesbuilding blocks - Gilles Subra

• Glycopeptide and lipopeptide derivatives with potent activity against multi-drug resistant pathogenic bacteria responsible for UTI, cSSSI and CAP/NP infections - Matt Cooper
• Is there a future for peptide mimetics as anti-microbial agents? - James Mahony
• Functional designed peptides: Antimicrobials and enzymes - Surajit Bhattacharyya
• Sub3, an antimicrobial peptide with cell-penetrating properties - Sonia T. Henriques
• Development of first-in-class adiponectin receptor agonist and antagonist peptides - Laszlo Otvos

Further workshop details comings shortly.

• Engineering stable disulfide-rich, cyclic scaffolds - Norelle L Daly
• Towards the development of rxfp1 receptor specific minimised relaxin analogue - M. Akhter Hossain
• Medicinal Chemistry of Peptidic Compounds for the Treatment of Muscular Diseases - Yoshio Hayashi
• Self-assembling cages from de novo designed peptide modules - Jordan M Fletcher
• New methods for amide bond formation - Craig A Hutton

• Utility of Peptide Ligation Chemistry for the Chemical Synthesis of Post-Translationally Modified Peptides and Proteins - Richard J Payne

• Development of a Universal Influenza Synthetic Peptide Vaccine - Robert Hodges